You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
VA patients will now have access to Polymedco's colorectal cancer screening products, including the Epigenomics Epi proColon.
The contract provides coverage of ConfirmMDx testing at the Medicare rate for veterans within the VA health system.
The company will apply artificial intelligence to a large clinical and genomic dataset from VA records in order to support personalized clinical decision making.
The new partnership will make data from more than 9 million anonymized veterans' medical records available for research.
The company has been working with the VA since 2013, when it it received a contract to provide sequencing and data analysis for enrollees in the Million Veteran Program.
Announced this month, the project brings together CPTAC, the VA, and DoD, and has as its initial goal the proteogenomic analysis of 8,000 lung cancer patients.
With NIH funds, organizations will build the 1 million volunteer cohort, while FDA's draft guidances will inform regulation of genetic tests critical for precision medicine.
The deal, which will help develop personalized cancer treatments for veterans, marks the latest in a series of personalized medicine alliances for IBM.
The work will support the Million Veteran Program, which aims to study the link between genes and disease using a research cohort veterans and active military.
Dozens of government agencies, academic institutions, and a various public and private sector organizations have now committed to driving the initiative forward.
The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.
In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.